Servier to Acquire Exclusive Worldwide Rights of BioNova’s BN104, a potential best-in-class menin inhibitor
Discover Servier
Shining a Light on Chondrosarcoma: A Rare Disease with Urgent Needs
Servier’s Golden Ticket goes to Viska Bio for its innovative scientific approach in hard-to-treat cancers